• Beauchamp, Richard


    Investigator Emeritus, BC Children's Hospital
    Clinical Professor, Department of Orthopedics, Faculty of Medicine, University of British Columbia

    Degrees / Designations
    Primary Area of Research
    Childhood Diseases
    Secondary Area(s) of Research
    604-875-2000 ext. 3464
    Lab Phone
    Judy Woodward
    Assistant Phone
    Mailing Address

    BC Children's Hospital
    Department of Orthopaedics
    A205B-4480 Oak Street
    Vancouver BC, V6H 3V4

    Affiliate Websites
    Research Areas
    • Cerebral Palsy
    • Botulinum toxin
    • Spasticity
    • Functional Outcomes
    • Spina Bifida
    • Gait

    My research is focused on clinical outcomes in the area of Neuromuscular disorders such as Cerebral Palsy and Spina Bifida as well as investigations of various gait (movement) disorders. My clinical practice involves working with a wide array of patients, many of which have neuromuscular disorders involving severe spasticity. Spasticity occurs when there is a defect in the Central Nervous System that causes certain muscles to continuously tighten and contract. Treatments for this debilitating condition involve the use of botulinum toxin (Botox) which is the injection into the muscle which blocks the nerves from causing the muscles to contract. One area of my research and clinical practice involves investigating the functional outcomes of children who receive Botox treatments for spasticity.

    Current Projects

    One research project that I am currently involved in is a prospective observational database designed to collect data on patient reported outcomes in individuals using Botox for medical reasons. Botulinum toxin (Botox) is used medically to reduce spasticity of muscles, however, the outcomes of this are not measureable through radiographs or other clinical exams. Clinicians are able to see if the botox has had its effect (i.e. if the limb is no longer spastic), however, whether or not the botox is helping the patient functionally remains unknown. Therefore, it is the objective of this study to determine the functional outcomes of Botox when used for medical purposes. In order to achieve this, 50 Specialists across Canada are involved in administering functional outcome questionnaires (SF-12 Health and Well-being Questionnaire and the Global Rating of Change Questionnaire) to their patients who are receiving botox treatments.

    A second research project that I am currently involved in is investigating the treatment pattern of Cerebral Palsy with Botulinum Toxin (Botox) in Canada. It is a Practice Assessment Program designed as a prospective audit of physician practice patterns. Many physicians in Canada are currently using Botox as a treatment for Cerebral Palsy but little is known about which physicians are prescribing it and which types of patients they are prescribing its use for. The objective of this study is to gather information on practice patterns related to treatment of Botox injection for Cerebral Palsy and to explore the relationship between the patterms of cerebral palsy indication treatment with the use of Botox injections.  

    Selected Publications

    Steinbok P, Hicdonmez T, Sawatzky B, Beauchamp R, Wickenheiser D. Spinal deformities after selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg. 2005 May;102(4 Suppl):363-73.

    White NJ, Cochrane DD, Beauchamp R. Paraparesis caused by an angiolipomatous hamartoma in an adolescent with Proteus syndrome and scoliosis Journal of Neurosurgery 2005 Sep;103(3 Suppl):282-4.

    Hicdonmez T, Steinbok P, Beauchamp R, Sawatzky B. Hip Joint Subluxation after Selective Dorsal Rhizotomy for Spastic Cerebral Palsy Journal of Neurosurgery. 2005 Jul;103(1 Suppl):10-6.

    Alvarez CM. Tredwell SJ. Keenan SP. Beauchamp RD. Choit RL. Sawatzky BJ. De Vera MA. Treatment of idiopathic clubfoot utilizing botulinum A toxin: a new method and its short-term outcomes. Journal of Pediatric Orthopedics. 25(2):229-35, 2005 Mar-Apr.

    Dulai SK, Slobogean BL, Beauchamp RD, Mulpuri K.  A quality assessment of randomized clinical trials in pediatric orthopaedics. Journal of Pediatric Orthop. 2007 Jul-Aug;27(5):573-81.

    Alvarez CM, De Vera MA, Beauchamp RD, Ward V, Black A. Classification of idiopathic toe walking based  on gait analysis: Development and application of the ITW severity classification. Gait & Posture. 2007 Sept: 26(3): 428-35.

    “Spasticity in Spina Bifida” Authors: Cochrane DD, Beauchamp R, King C, MacNeily A.   In: The Spina Bifida: Management and Outcome.  Springer-Verlag Italia 2008, Milan, Italy. Editors Ozek MM, Cinalli G, Maixner WJ.

    Honours & Awards

    Special Recognition for 25 years service from “The Centre for Child Development” Surrey B.C., May 3, 2009

    Educational Award of Excellence with Distinction. Children & Women’s Health Centre of British Columbia, May 23,  2003

    Merit Award, Fraternity To Help Guatemalan Children, April 28, 2001

    Richmond Cerebral Palsy Award, American Academy Cerebral Palsy in Child Developmental Medicine, Portland, Oregon, with Dr. Paul Steinbok, September 1997.

    Diplomat, American Board of Orthopaedic Surgery, 1980.

    Research Group Members
    • Chris Reilly, MD, FRCSC
    • Firoz Miyanji, MD, FRCSC
    • Kishore Mulpuri, MD, MHSc (Epi)
    • Christine Alvarez, MD, FRCSC
    • Tanya Mayson, MSc, BSc PT
    • Alec Black, MSc
    • Jessica Maurer, MSc
    • Valerie Ward, BSc PT